Likewise, AR is expressed in approximately 70% to 90% of invasive breast cancers, a frequency comparable with or higher than the one reported for ER (70–80%) and PgR (50–70%) [1,7-10]. This evidence concerns the gene AR and invasive breast carcinoma.